180 related articles for article (PubMed ID: 20708467)
21. Topical tacrolimus therapy for pyoderma gangrenosum.
Chiba T; Isomura I; Suzuki A; Morita A
J Dermatol; 2005 Mar; 32(3):199-203. PubMed ID: 15863867
[TBL] [Abstract][Full Text] [Related]
22. Pyoderma gangrenosum in the genital area: successful treatment using adalimumab.
Bardazzi F; Magnano M; Tengattini V; Loi C
Eur J Dermatol; 2018 Apr; 28(2):263-264. PubMed ID: 29378677
[No Abstract] [Full Text] [Related]
23. Pyoderma gangrenosum--case report.
Abela CB; Soldin M; Gateley D
Br J Oral Maxillofac Surg; 2007 Jun; 45(4):328-30. PubMed ID: 16360244
[TBL] [Abstract][Full Text] [Related]
24. Low-dose tissue plasminogen activator for calciphylaxis.
Sewell LD; Weenig RH; Davis MD; McEvoy MT; Pittelkow MR
Arch Dermatol; 2004 Sep; 140(9):1045-8. PubMed ID: 15381542
[No Abstract] [Full Text] [Related]
25. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
Patel GK; Rhodes JR; Evans B; Holt PJ
J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous ulceration in an infant.
Garbayo Salmons P; Casals Andreu M; Casulleras González A; López LLunell C; Luelmo Aguilar J
Pediatr Dermatol; 2019 Nov; 36(6):e113-e114. PubMed ID: 31778570
[No Abstract] [Full Text] [Related]
27. Successful treatment of postoperative pyoderma gangrenosum with cyclosporin.
Schöfer H; Baur S
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):148-51. PubMed ID: 12046819
[TBL] [Abstract][Full Text] [Related]
28. Pyoderma gangrenosum following breast reconstruction.
MacKenzie D; Moiemen N; Frame JD
Br J Plast Surg; 2000 Jul; 53(5):441-3. PubMed ID: 10876288
[TBL] [Abstract][Full Text] [Related]
29. Pyoderma gangrenosum in an infant.
Torrelo A; Colmenero I; Serrano C; Vilanova A; Naranjo R; Zambrano A
Pediatr Dermatol; 2006; 23(4):338-41. PubMed ID: 16918628
[TBL] [Abstract][Full Text] [Related]
30. Solitary ulceration on anterior left leg.
Levine N
Geriatrics; 2007 Feb; 62(2):25. PubMed ID: 17291139
[No Abstract] [Full Text] [Related]
31. Cutaneous blastomycosis: a diagnostic challenge.
Mason AR; Cortes GY; Cook J; Maize JC; Thiers BH
Int J Dermatol; 2008 Aug; 47(8):824-30. PubMed ID: 18717863
[TBL] [Abstract][Full Text] [Related]
32. Postsurgical pyoderma gangrenosum successfully treated with cyclosporine.
Behera B; Chandrashekar L; Thappa DM; Srinivas BH; Pasayat PP; Laroiya I
Indian J Dermatol Venereol Leprol; 2017; 83(3):412. PubMed ID: 27852992
[No Abstract] [Full Text] [Related]
33. [Local treatment of pyoderma gangrenosum with cromoglycate solution].
Harvima RJ; Hollmén A; Mattila R; Kaipiainen-Seppänen O; Harvima IT; Kaminska R; Laukkanen A; Räsänen L; Horsmanheimo M
Duodecim; 1999; 115(19):2085-90. PubMed ID: 11941802
[No Abstract] [Full Text] [Related]
34. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.
Bellini V; Simonetti S; Lisi P
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):113-5. PubMed ID: 18181988
[No Abstract] [Full Text] [Related]
35. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
36. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
37. Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody.
Parmentier L; Bron BA; Prins C; Samson J; Masouyé I; Borradori L
Arch Dermatol; 2008 Nov; 144(11):1427-30. PubMed ID: 19015416
[No Abstract] [Full Text] [Related]
38. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
39. High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum.
Greb JE; Gottlieb AB; Goldminz AM
Dermatol Ther; 2016 Nov; 29(6):482-483. PubMed ID: 27502191
[No Abstract] [Full Text] [Related]
40. Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy.
Teasley LA; Foster CS; Baltatzis S
Cornea; 2007 Feb; 26(2):215-9. PubMed ID: 17251816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
